Abstract
Several animal models for Huntington’s disease (HD) have been created in order to investigate mechanisms of disease, and to evaluate the potency of novel therapies. Here, we describe the characteristics of the two transgenic rat models: transgenic rat model of HD (fragment model) and the Bacterial Artificial Chromosome HD model (full-length model). We discuss their genetic, behavioural, neuropathological and neurophysiological features.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aitman TJ, Critser JK, Cuppen E, Dominiczak A, Fernandez-suarez XM, Flint J, Gauguier D, Geurts AM, Gould M, Harris PC, Holmdahl R, Hubner N, Izsvak Z, Jacob HJ, Kuramoto T, Kwitek AE, Marrone A, Mashimo T, Moreno C, Mullins J, Mullins L, Olsson T, Pravenec M, Riley L, Saar K, Serikawa T, Shull JD, Szpirer C, Twigger SN, Voigt B, Worley K (2008) Progress and prospects in rat genetics: a community view. Nat Genet 40:516–522
Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA, Bonin M, Nguyen HP, Riess O, Bauer A, Sjoberg C, Petersen A, Von horsten S (2008) Sex differences in a transgenic rat model of Huntington’s disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum Mol Genet 17: 2595–2609
Brooks S, Fielding S, Dobrossy M, Von horsten S, Dunnett S (2009) Subtle but progressive cognitive deficits in the female tgHD hemizygote rat as demonstrated by operant SILT performance. Brain Res Bull 79:310–315
Cao C, Temel Y, Blokland A, Ozen H, Steinbusch HW, Vlamings R, Nguyen HP, Von horsten S, Schmitz C, Visser-vandewalle V (2006) Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington’s disease transgenic ratmodel. Behav Brain Res 170:257–261
Fielding SA, Brooks SP, Klein A, Bayram-weston Z, Jones L, Dunnett SB (2012) Profiles of motor and cognitive impairment in the transgenic rat model of Huntington’s disease. Brain Res Bull 88:223–236
Frank S, Jankovic J (2010) Advances in the pharmacological management of Huntington’s disease. Drugs 70:561–571
Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28:6182–6195
Hohn S, Dallerac G, Faure A, Urbach YK, Nguyen HP, Riess O, Von horsten S, Le blanc P, Desvignes N, El massioui N, Brown BL, Doyere V (2011) Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease. J Neurosci 31:8986–8997
Holzmann C, Maueler W, Petersohn D, Schmidt T, Thiel G, Epplen JT, Riess O (1998) Isolation and characterization of the rat huntingtin promoter. Biochem J 336(Pt 1):227–234
Jahanshahi A, Vlamings R, Kaya AH, Lim LW, Janssen ML, Tan S, Visser-vandewalle V, Steinbusch HW, Temel Y (2010) Hyperdopaminergic status in experimental Huntington disease. J Neuropathol Exp Neurol 69:910–917
Jahanshahi A, Vlamings R, Roon-mom WV, Faull RL, Waldvogel HJ, Janssen ML, Yakkioui Y, Zeef D, Kocabicak E, Steinbusch HW, Temel Y (2013). Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington’s disease. Neuroscience 238:71–81
Kantor O, Temel Y, Holzmann C, Raber K, Nguyen HP, Cao C, Turkoglu HO, Rutten BP, Visser-vandewalle V, Steinbusch HW, Blokland A, Korr H, Riess O, Von horsten S, Schmitz C (2006) Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington’s disease transgenic rats. Neurobiol Dis 22:538–547
Kirch RD, Meyer PT, Geisler S, Braun F, Gehrig S, Langen KJ, Von horsten S, Nikkhah G, Cassel JC, Dobrossy MD (2013) Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington’s disease. Behav Brain Res 239:15–26
Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996) Executive and mnemonic functions in early Huntington’s disease. Brain 119(Pt 5):1633–1645
Miller BR, Walker AG, Fowler SC, Von horsten S, Riess O, Johnson MA, Rebec GV (2010) Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington’s disease. Neurobiol Dis 37:106–113
Nguyen HP, Kobbe P, Rahne H, Worpel T, Jager B, Stephan M, Pabst R, Holzmann C, Riess O, Korr H, Kantor O, Petrasch-parwez E, Wetzel R, Osmand A, Von horsten S (2006) Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington’s disease. Hum Mol Genet 15:3177–3194
Ortiz AN, Osterhaus GL, Lauderdale K, Mahoney L, Fowler SC, Von horsten S, Riess O, Johnson MA (2012) Motor function and dopamine release measurements in transgenic Huntington’s disease model rats. Brain Res 1450:148–156
Schmidt T, Landwehrmeyer GB, Schmitt I, Trottier Y, Auburger G, Laccone F, Klockgether T, Volpel M, Epplen JT, Schols L, Riess O (1998) An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol 8:669–679
Schmitt I, Bachner D, Megow D, Henklein P, Hameister H, Epplen JT, Riess O (1995) Expression of the Huntington disease gene in rodents: cloning the rat homologue and evidence for downregulation in non-neuronal tissues during development. Hum Mol Genet 4:1173–1182
Temel Y, Visser-Vandewalle V, van der Wolf M, Desbonnet L, Spincemaille GH, Hoogland G, Steinbusch HWM (2004) Monopolar versus bipolar high frequency stimulation of the rat subthalamic nucleus: differences in histological damage. Neurosci Lett 367(1):92–96
Vandeputte C, Taymans JM, Casteels C, Coun F, Ni Y, Van laere K, Baekelandt V (2010) Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci 11:92
Verwaest KA, Vu TN, Laukens K, Clemens LE, Nguyen HP, Van Gasse B, Martins JC, Van der Linden A, Dommisse R (2011) (1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington's disease. Biochim Biophys Acta Nov;1812(11):1371–1379. doi: 10.1016/j.bbadis.2011.08.001
Vlamings R, Benazzouz A, Chetrit J, Janssen ML, Kozan R, Visser-vandewalle V, Steinbusch HW, Von horsten S, Temel Y (2012a) Metabolic and electrophysiological changes in the basal ganglia of transgenic Huntington’s disease rats. Neurobiol Dis 48:488–494
Vlamings R, Zeef DH, Janssen ML, Oosterloo M, Schaper F, Jahanshahi A, Temel Y (2012b) Lessons learned from the transgenic Huntington’s disease rats. Neural Plast 2012:682712
Von horsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-hartlieb S, Schulz JB, Grasshoff U, Bauer I, Vieira-saecker AM, Paul M, Jones L, Lindenberg KS, Landwehrmeyer B, Bauer A, Li XJ, Riess O (2003) Transgenic rat model of Huntington’s disease. Hum Mol Genet 12:617–624
Yu-taeger L, Petrasch-parwez E, Osmand AP, Redensek A, Metzger S, Clemens LE, Park L, Howland D, Calaminus C, Gu X, Pichler B, Yang XW, Riess O, Nguyen HP (2012) A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease. J Neurosci 32:15426–15438
Zeef DH, Van goethem NP, Vlamings R, Schaper F, Jahanshahi A, Hescham S, Von horsten S, Prickaerts J,Temel Y (2012a) Memory deficits in the transgenic rat model of Huntington’s disease. Behav Brain Res 227:194–198
Zeef DH, Vlamings R, Lim LW, Tan S, Janssen ML, Jahanshahi A, Hoogland G, Prickaerts J, Steinbusch HW, Temel Y (2012b) Motor and non-motor behaviour in experimental Huntington’s disease. Behav Brain Res 226:435–439
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Carreira, J.C. et al. (2013). Transgenic Rat Models of Huntington’s Disease. In: Nguyen, H., Cenci, M. (eds) Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease. Current Topics in Behavioral Neurosciences, vol 22. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7854_2013_245
Download citation
DOI: https://doi.org/10.1007/7854_2013_245
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46343-7
Online ISBN: 978-3-662-46344-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)